首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human IFNG Recombinant Antibody(Fontolizumab)

Anti-Human IFNG Recombinant Antibody(Fontolizumab)

产品编号

YR1022

别名

科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Fontolizumab ( 芳妥珠单抗 ), Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab
Catalog NumberYR1022
Molecular NameFontolizumab
CAS Number326859-36-3
TargetIFNG[Homo sapiens]
Antibody IsotypeIgG1
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundFontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.
ApplicationIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价